It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
To better understand how amino acid sequence encodes protein structure, we engineered mutational pathways that connect three common folds (3α, β−grasp, and α/β−plait). The structures of proteins at high sequence-identity intersections in the pathways (nodes) were determined using NMR spectroscopy and analyzed for stability and function. To generate nodes, the amino acid sequence encoding a smaller fold is embedded in the structure of an ~50% larger fold and a new sequence compatible with two sets of native interactions is designed. This generates protein pairs with a 3α or β−grasp fold in the smaller form but an α/β−plait fold in the larger form. Further, embedding smaller antagonistic folds creates critical states in the larger folds such that single amino acid substitutions can switch both their fold and function. The results help explain the underlying ambiguity in the protein folding code and show that new protein structures can evolve via abrupt fold switching.
In this work the authors investigate the structure-sequence dependance. The ability to design and characterize proteins at interfaces between three common folds suggests that fold switching is an intrinsic feature of protein folding language and likely important in the evolution of protein structure and function.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Potomac Affinity Proteins, North Potomac, USA (GRID:grid.423246.5)
2 University of Maryland, Institute for Bioscience and Biotechnology Research, Rockville, USA (GRID:grid.440664.4) (ISNI:0000 0001 0313 4029)
3 Potomac Affinity Proteins, North Potomac, USA (GRID:grid.423246.5); University of Maryland, Department of Bioengineering, College Park, USA (GRID:grid.164295.d) (ISNI:0000 0001 0941 7177)
4 University of Maryland, Institute for Bioscience and Biotechnology Research, Rockville, USA (GRID:grid.440664.4) (ISNI:0000 0001 0313 4029); University of Maryland, Department of Chemistry and Biochemistry, College Park, USA (GRID:grid.164295.d) (ISNI:0000 0001 0941 7177)
5 University of Maryland, Institute for Bioscience and Biotechnology Research, Rockville, USA (GRID:grid.440664.4) (ISNI:0000 0001 0313 4029); National Institute of Standards and Technology and the University of Maryland, Rockville, USA (GRID:grid.94225.38) (ISNI:000000012158463X)
6 Potomac Affinity Proteins, North Potomac, USA (GRID:grid.423246.5); University of Maryland, Institute for Bioscience and Biotechnology Research, Rockville, USA (GRID:grid.440664.4) (ISNI:0000 0001 0313 4029)